Cristiano Gonçalves Pereira
Cited by
Cited by
Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1α and oxidative phosphorylation in melanoma
YNV Gopal, H Rizos, G Chen, W Deng, DT Frederick, ZA Cooper, ...
Cancer research 74 (23), 7037-7047, 2014
Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target
G Chen, N Chakravarti, K Aardalen, AJ Lazar, MT Tetzlaff, B Wubbenhorst, ...
Clinical Cancer Research 20 (21), 5537-5546, 2014
Emerging patent landscape for non-viral vectors used for gene therapy
V Picanço-Castro, CG Pereira, DT Covas, GS Porto, A Athanassiadou, ...
Nature biotechnology 38 (2), 151-157, 2020
Forecasting of emerging therapeutic monoclonal antibodies patents based on a decision model
CG Pereira, JR Lavoie, E Garces, F Basso, M Dabić, GS Porto, T Daim
Technological Forecasting and Social Change 139, 185-199, 2019
Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation
BCMF Paes, PD Moço, CG Pereira, GS Porto, EM de Sousa Russo, ...
Cell biology and toxicology 33 (3), 233-250, 2017
RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma
L Goedert, CG Pereira, J Roszik, JR Plaça, C Cardoso, G Chen, W Deng, ...
Oncotarget 7 (24), 36711, 2016
Different isolates from Leishmania braziliensis complex induce distinct histopathological features in a murine model of infection
CG Pereira, ALN Silva, P de Castilhos, EC Mastrantonio, RA Souza, ...
Veterinary parasitology 165 (3-4), 231-240, 2009
Patent mining and landscaping of emerging recombinant factor VIII through network analysis
CG Pereira, V Picanco-Castro, DT Covas, GS Porto
Nature biotechnology 36 (7), 585-590, 2018
Novel primate-specific genes, RMEL 1, 2 and 3, with highly restricted expression in melanoma, assessed by new data mining tool
JF Sousa, R Torrieri, RR Silva, CG Pereira, V Valente, E Torrieri, ...
PloS one 5 (10), e13510, 2010
Technological cooperation network in biotechnology: Analysis of patents with Brazil as the priority country
CG Pereira, RR Da Silva, JR Lavoie, GS Porto
Innovation & Management Review, 2018
A typical presentation of cutaneous leishmaniasis after renal transplantation
FA Vinhal, SR Afonso-Cardoso, AG Silva, CG Pereira, W Sousa, ...
Nephrology Dialysis Transplantation 22 (12), 3674-3674, 2007
The lncRNA RMEL3 protects immortalized cells from serum withdrawal‐induced growth arrest and promotes melanoma cell proliferation and tumor growth
C Cardoso, RB Serafim, A Kawakami, C Gonçalves Pereira, J Roszik, ...
Pigment cell & melanoma research 32 (2), 303-314, 2019
Effects of Bothrops moojeni venom on Leishmania amazonensis promastigote forms
P Castilhos, CG Pereira, ALN Silva, DR Napolitano, F Oliveira, MA Souza
Journal of Venomous Animals and Toxins including Tropical Diseases 17, 150-158, 2011
Emerging CAR T cell therapies: clinical landscape and patent technological routes
V Picanco-Castro, C Gonçalves Pereira, K Swiech, ...
Human vaccines & immunotherapeutics 16 (6), 1424-1433, 2020
Cooperation and technological areas in the state universities of São Paulo: An analysis from the perspective of the triple helix model
FG Basso, CG Pereira, GS Porto
Technology in Society 65, 101566, 2021
Uncovering innovation features and emerging technologies in molecular biology through patent analysis
CG Pereira, GS Porto
Recombinant Glycoprotein Production, 15-34, 2018
The scientific information provided through patents and its limited use in scientific research at universities
CG Pereira, RR Da Silva, GS Porto
Brazilian Journal of Science and Technology 2 (1), 1-11, 2015
Political and electoral accountability enhances accountability: a comparative analysis of courts of accounts in Brazil
M Figueiredo, M Melo, C Pereira
International Congress of Lasa, 2005
Gestão de sistemas de informação
L Amaral, A Andrade, C Pereira, P Morais
Edições Sílabo, 2022
Technology Intelligence Map: Biotechnology
CG Pereira, JR Lavoie, A Shaygan, TU Daim, MAO Luqueze, GS Porto
Roadmapping Future, 461-489, 2021
The system can't perform the operation now. Try again later.
Articles 1–20